Medicine and Dentistry
Systemic Scleroderma
100%
Scleroderma
54%
Malignant Neoplasm
28%
Immune Checkpoint Inhibitor
24%
Pulmonary Hypertension
17%
Disease
16%
Rheumatoid Arthritis
14%
Raynaud Phenomenon
13%
Autoantibodies
11%
Calciphylaxis
11%
Immune-Related Adverse Events
10%
Rheumatology
10%
Telangiectasia
8%
Diagnosis
8%
Cancer Immunotherapy
7%
Interstitial Lung Disease
7%
Adverse Event
7%
Myositis
7%
Immunosuppressive Treatment
7%
Organ Systems
7%
Thyroid Disease
7%
Liver Disease
7%
Rheumatic Disease
6%
Symptom
6%
Bladder Dysfunction
6%
Sclerosis
6%
Patient-Reported Outcome
6%
Clinical Feature
5%
Dermatosis
5%
Cancer
5%
Biological Marker
5%
Diseases
5%
DNA Directed RNA Polymerase III
5%
Systolic Blood Pressure
5%
Immunotherapy
5%
Cancer Risk
5%
Patient Referral
5%
Oral Submucous Fibrosis
5%
Erectile Dysfunction
5%
Autoimmune Rheumatic Disease
5%
Avascular Necrosis
5%
Odds Ratio
5%
Keyphrases
Systemic Sclerosis
92%
Scleroderma
70%
Raynaud's Phenomenon
20%
Autoantibodies
20%
Immune Checkpoint Inhibitors
18%
Inflammatory Arthritis
14%
Interstitial Lung Disease
12%
Cancer Risk
12%
Pulmonary Hypertension
9%
Calcinosis
9%
Pulmonary Arterial Hypertension
9%
Confidence Interval
9%
Autoimmunity
8%
Diffuse Cutaneous Systemic Sclerosis
8%
Clinical Features
7%
Odds Ratio
7%
Immune-related Adverse Events
7%
Disease Severity
7%
Esophageal Dysmotility
6%
Right Ventricular
6%
Telangiectasia
6%
Immunosuppressive Therapy
5%
Clinical Presentation
5%
Clinical Manifestations
5%
Liver Disease
5%
Dermatomyositis
5%
Immunology and Microbiology
Systemic Scleroderma
91%
Scleroderma
73%
Autoantibodies
27%
Monospecific Antibody
22%
Inflammatory Arthritis
22%
Autoimmune Disease
11%
Immune Response
10%
Raynaud Phenomenon
10%
Myositis
9%
interferon
8%
Rheumatic Disease
7%
Immunosuppression
7%
RNA Polymerase
7%
Autoimmunity
6%
Forced Vital Capacity
6%
Computer Assisted Tomography
6%
Immunotherapy
6%
Prevalence
5%
Autoantigen
5%
Autoimmune Rheumatic Disease
5%
Epitope
5%
Cancer Immunotherapy
5%
